When the Brain Itself Becomes Inflamed
Encephalitis — inflammation of the brain — is among the most serious neurological conditions a dog can face. It can develop rapidly, transforming a seemingly healthy dog into one experiencing seizures, blindness, or profound behavioural changes within hours. In the United Kingdom, inflammatory brain diseases collectively represent a significant proportion of referrals to veterinary neurology services, and certain small breeds appear disproportionately at risk. Understanding what drives this condition can make the difference between early intervention and irreversible damage.
Types and Causes of Encephalitis
Encephalitis in dogs falls broadly into two categories: infectious and immune-mediated. In the UK, infectious causes are less common than immune-mediated forms, though both require urgent investigation.
Infectious Encephalitis
Canine distemper virus remains the most significant infectious cause globally, though vaccination has reduced its incidence dramatically in the UK. Bacterial encephalitis can result from extension of otitis media or interna into the brain, or from haematogenous spread of bacterial infection from elsewhere in the body. Fungal encephalitis, caused by organisms such as Cryptococcus, is rare in the UK but seen more frequently in immunosuppressed dogs. Tick-borne diseases including Anaplasma phagocytophilum have neurological manifestations in some cases. Toxoplasma gondii and Neospora caninum are protozoal causes, the latter particularly in young dogs.
Immune-Mediated Encephalitis
The most prevalent forms in the UK are immune-mediated inflammatory conditions that are not secondary to infection. Granulomatous meningoencephalomyelitis (GME) is the most commonly diagnosed, characterised by perivascular accumulations of inflammatory cells throughout the brain and spinal cord. Necrotising encephalitis (NE) and necrotising meningoencephalitis (NME) are distinct forms where brain tissue undergoes irreversible destruction, and are associated strongly with particular breeds. The trigger for these autoimmune attacks on brain tissue remains incompletely understood, but genetic predisposition clearly plays a role.
Breeds at Elevated Risk
Breed-associated necrotising encephalitides have been most consistently documented in:
- Pugs (Pug Dog Encephalitis — PDE is caused by NME): The most infamous breed association, with a progressive and unfortunately often fatal course.
- Yorkshire Terriers: NME affecting young to middle-aged individuals.
- Maltese: Described in the literature as particularly susceptible to NME.
- Chihuahuas: Both NME and NE have been documented.
- French Bulldogs: Increasing reports of inflammatory CNS disease as the breed's popularity has grown.
GME, by contrast, affects a broader range of small to medium-sized breeds and does not show the same restricted breed specificity. Large breeds are not exempt from encephalitis but are affected at lower rates by these immune-mediated forms.
Clinical Signs to Watch For
Signs depend on which region of the brain is primarily affected. Forebrain involvement commonly produces seizures, behavioural change, circling, visual deficits, and dementia-like signs. Brainstem involvement causes head tilt, nystagmus (involuntary eye movement), difficulty swallowing, and facial paralysis. Cerebellar disease produces a distinctive wobbly gait with preserved strength. Spinal cord involvement adds weakness or paralysis of the limbs. In many cases, multifocal signs are present simultaneously, which should raise immediate suspicion for an inflammatory rather than a simple focal lesion.
Diagnosis
MRI of the brain is the essential first investigation and typically reveals signal abnormalities, mass lesions, or contrast enhancement patterns suggestive of inflammation. However, MRI cannot definitively distinguish between GME, NME, and NE — nor can it reliably exclude infectious causes. Cerebrospinal fluid (CSF) analysis, obtained by lumbar or cisternal puncture under general anaesthesia, provides crucial information about cell type and protein levels. Infectious disease panels — including PCR for distemper, Toxoplasma, and Neospora — should be run on CSF and serum. Definitive diagnosis of necrotising forms traditionally requires histopathology, though advances in MRI pattern recognition have improved ante-mortem differentiation.
Treatment Approaches
Where infectious causes are confirmed, specific antimicrobial, antifungal, or antiprotozoal therapy is the priority. For immune-mediated encephalitides, immunosuppression is the cornerstone of treatment.
Corticosteroids
High-dose prednisolone or dexamethasone remains the first-line therapy for GME, rapidly reducing inflammation. Long-term use at lower doses is typically required to prevent relapse.
Combination Immunosuppression
In cases where steroids alone provide incomplete control, or where side effects are prohibitive, combination protocols are used. Cytosine arabinoside (cytarabine), given as an infusion, has shown considerable promise in GME and is now widely used at specialist referral centres. Mycophenolate mofetil, ciclosporin, and lomustine are additional agents employed in refractory cases. Treatment for necrotising encephalitides follows similar immunosuppressive principles, though the prognosis for NME in Pugs and Yorkies is generally more guarded.
Seizure Management
Anti-epileptic drugs — most commonly phenobarbital, levetiracetam, or potassium bromide — are used concurrently in dogs presenting with seizures, as seizure control is essential for short-term welfare and safety.
Always seek referral to a veterinary neurologist promptly if encephalitis is suspected. The prognosis is highly variable and condition-specific, but early, aggressive immunosuppression in immune-mediated cases offers the best chance of meaningful remission.
- Do not delay neurological referral if your dog has seizures combined with behavioural change or other neurological signs.
- Ensure vaccination is current — distemper remains preventable.
- In at-risk breeds, know the early signs: behaviour shifts, subtle circling, and light sensitivity can precede more dramatic presentations.
- Prepare for long-term medication management; most immune-mediated encephalitides require ongoing treatment.